drugset / Trial / NCT00366626

Effectiveness of Naltrexone Versus Placebo to Reduce Craving for Alcohol With Evaluation of Genetic Variability.

NCT00366626

Phase 4 Completed 83 enrolled Medical University of South Carolina
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether naltrexone (an opiate blocking agent approved for the treatment of alcohol dependence) is more effective in the reduction of alcohol craving and drinking compared to placebo in individuals with particular genetic predisposition.

Timeline

Start
2006-04
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule 50 mg

Indications